Advertisement
Screener

ALPHATEC HOLDINGS, INC. (ATEC) Goodwill, Foreign Currency Translation Gain (Loss)

2.8 / 5 stars · 68/120 Roast Me

ALPHATEC HOLDINGS, INC. Goodwill, Foreign Currency Translation Gain (Loss)

ALPHATEC HOLDINGS, INC. (ATEC) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$1.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Other Income

us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-04

  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$303.00K, a 110.51% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$738.00K, a 154.34% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $9.00K.
  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$19.00K, a 101.37% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $4.23M.
  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$2.03M, a 292.31% decline from fiscal 2023.
  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $1.05M.
  • ALPHATEC HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$1.54M.
Period endGoodwill, Foreign Currency Translation Gain (Loss) 3 monthGoodwill, Foreign Currency Translation Gain (Loss) 6 monthGoodwill, Foreign Currency Translation Gain (Loss) 9 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 month
2026-06-30-$303.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$1.04M
10-Q · filed 2026-08-04
-$1.03M
derived: sum of 3 quarters · filed 2026-08-04
-$1.05M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$738.00K
10-Q · filed 2026-05-05
-$729.00K
derived: sum of 2 quarters · filed 2026-05-05
-$748.00K
derived: sum of 3 quarters · filed 2026-05-05
$2.14M
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31$9.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$10.00K
derived: sum of 2 quarters · filed 2026-02-24
$2.87M
derived: sum of 3 quarters · filed 2026-02-24
$4.23M
10-K · filed 2026-02-24
2025-09-30-$19.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$2.87M
derived: sum of 2 quarters · filed 2025-10-30
$4.22M
10-Q · filed 2025-10-30
$1.80M
derived: sum of 4 quarters · filed 2025-10-30
2025-06-30$2.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$4.24M
10-Q · filed 2025-07-31
$1.82M
derived: sum of 3 quarters · filed 2025-07-31
$3.21M
derived: sum of 4 quarters · filed 2025-07-31
2025-03-31$1.36M
10-Q · filed 2025-05-01
-$1.06M
derived: sum of 2 quarters · filed 2025-05-01
$326.00K
derived: sum of 3 quarters · filed 2025-05-01
$85.00K
derived: sum of 4 quarters · filed 2025-05-01
2024-12-31-$2.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
-$1.03M
derived: sum of 2 quarters · filed 2025-02-26
-$1.27M
derived: sum of 3 quarters · filed 2025-02-26
-$2.03M
10-K · filed 2025-02-26
2024-09-30$1.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$1.15M
derived: sum of 2 quarters · filed 2024-10-30
$394.00K
10-Q · filed 2024-10-30
$1.84M
derived: sum of 4 quarters · filed 2024-10-30
2024-06-30-$241.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
-$995.00K
10-Q · filed 2024-07-31
$453.00K
derived: sum of 3 quarters · filed 2024-07-31
-$519.00K
derived: sum of 4 quarters · filed 2024-07-31
2024-03-31-$754.00K
10-Q · filed 2024-05-07
$694.00K
derived: sum of 2 quarters · filed 2024-05-07
-$278.00K
derived: sum of 3 quarters · filed 2024-05-07
-$257.00K
derived: sum of 4 quarters · filed 2024-05-07
2023-12-31$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$476.00K
derived: sum of 2 quarters · filed 2024-02-27
$497.00K
derived: sum of 3 quarters · filed 2024-02-27
$1.05M
10-K · filed 2024-02-27
2023-09-30-$972.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
-$951.00K
derived: sum of 2 quarters · filed 2023-11-06
-$394.00K
10-Q · filed 2023-11-06
$1.79M
derived: sum of 4 quarters · filed 2023-11-06
2023-06-30$21.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$578.00K
10-Q · filed 2023-08-03
$2.76M
derived: sum of 3 quarters · filed 2023-08-03
$1.18M
derived: sum of 4 quarters · filed 2023-08-03
2023-03-31$557.00K
10-Q · filed 2023-05-04
$2.74M
derived: sum of 2 quarters · filed 2023-05-04
$1.16M
derived: sum of 3 quarters · filed 2023-05-04
-$499.00K
derived: sum of 4 quarters · filed 2023-05-04
2022-12-31$2.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$605.00K
derived: sum of 2 quarters · filed 2023-02-28
-$1.06M
derived: sum of 3 quarters · filed 2023-02-28
-$1.54M
10-K · filed 2023-02-28
2022-09-30-$1.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$3.24M
derived: sum of 2 quarters · filed 2022-11-03
-$3.72M
10-Q · filed 2022-11-03
2022-06-30-$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$2.15M
10-Q · filed 2022-08-04
2022-03-31-$486.00K
10-Q · filed 2022-05-05
2021-12-31-$2.05M
10-K · filed 2022-03-02
2015-12-31-$7.07M
10-K · filed 2017-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
NovoCure Ltd (NVCR)$1.886B-11.87
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66